Trust Company’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.1K Hold
1,988
﹤0.01% 285
2026
Q1
$50.2K Buy
1,988
+8
+0.4% +$204 ﹤0.01% 298
2025
Q4
$50.5K Buy
1,980
+1
+0.1% +$26 ﹤0.01% 290
2025
Q3
$50.7K Hold
1,979
0.01% 217
2025
Q2
$50K Hold
1,979
0.01% 219
2025
Q1
$49.5K Hold
1,979
0.01% 228
2024
Q4
$48.6K Hold
1,979
0.01% 229
2024
Q3
$50.9K Buy
+1,979
New +$50K 0.01% 199

Other funds holding IBDX

Trust Company's IBDX Position: Q2 2026 in Review

Trust Company held its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) position steady in Q2 2026 at 1,988 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Trust Company first reported a position in IBDX in Q3 2024 and has held it in 8 quarters since. The position peaked at $50.9K in Q3 2024. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Trust Company held 1,988 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $50.1K as of Q2 2026.
  • Trust Company left its iShares iBonds Dec 2032 Term Corporate ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #285 holding.
  • Trust Company first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2024 and has held it in 8 quarters since.
  • Trust Company's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $50.9K in Q3 2024.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.